title: Initial reduction of oxidative stress by angiotensin receptor blocker contributes long term outcomes after percutaneous coronary intervention.
abstract: BACKGROUND
  It remains unclear whether administration of ARB with reactive oxygen species (ROS) scavenging effects improves the prognosis of patients undergoing PCI.
  
  
  OBJECTIVE
  This study investigated whether the pre-intervention antioxidant effect of angiotensin receptor blocker (ARB) affects long-term outcomes in patients after successful percutaneous coronary intervention (PCI) without early adverse events.
  
  
  METHODS
  Fifty-two patients who underwent elective PCI were randomly assigned for treatment with or without ARB, which was administered within 48 hours before PCI. ROS levels in mononuclear cells (MNCs) and serum superoxide dismutase (SOD) activity were measured pre-PCI and 6 months post-PCI. After exclusion of unexpected early adverse events during angiographic follow-up period, the long-term outcome (major adverse cerebro-cardiovascular event; MACCE) was assessed in eligible patients.
  
  
  RESULTS
  Forty-three patients (non-ARB n = 22, ARB n = 21) were followed up in this study. During angiographic follow-up period, ROS formation in MNCs was significantly increased in the non-ARB group (from 29.4 [21.6-35.2] to 37.2 [30.7-45.1] arbitrary units; p = 0.031) compared to that in the ARB group. Meanwhile, SOD activity was significantly impaired in the non-ARB group alone (from 24.0 ± 17.0 to 16.3 ± 13.8%, p = 0.004). During the follow-up period (median, 63.3 months), MACCEs were observed in 6 patients. The cumulative event ratio of MACCE was significantly higher in the non-ARB group than in the ARB group (p = 0.018).
  
  
  CONCLUSIONS
  Concomitant administration of ARB effectively reduced ROS production of PCI patients during angiographic follow-up period. Initial ROS inhibition following ARB administration may contribute to improvement of worse outcomes in patients who have undergone successful PCI.
authors: Department of Cardiology, Asahikawa Medical University Japan.
authors: Tadanori
authors: T
authors: Noro
authors: Department of Cardiovascular Regeneration and Innovation, Asahikawa Medical University Japan.
authors: Naofumi
authors: N
authors: Takehara
authors: Department of Cardiology, Asahikawa Medical University Japan.
authors: Kazuhiro
authors: K
authors: Sumitomo
authors: Department of Cardiology, Asahikawa Medical University Japan.
authors: Toshiharu
authors: T
authors: Takeuchi
authors: Department of Cardiology, Asahikawa City Hospital Japan.
authors: Yoshinao
authors: Y
authors: Ishii
authors: Department of Cardiology, Asahikawa Kosei General Hospital Japan.
authors: Jun-Ichi
authors: J
authors: Kato
authors: Department of Cardiovascular Regeneration and Innovation, Asahikawa Medical University Japan.
authors: Jun-Ichi
authors: J
authors: Kawabe
authors: Department of Cardiology, Asahikawa Medical University Japan.
authors: Naoyuki
authors: N
authors: Hasebe
keywords: Angiotensin receptor blocker; PCI; ROS; mononuclear cells; oxidative stress
references: Free Radic Biol Med. 2006 Mar 15;40(6):983-91
references: 16540394
references: BMB Rep. 2011 Aug;44(8):497-505
references: 21871172
references: Nat Clin Pract Cardiovasc Med. 2008 Jun;5(6):338-49
references: 18461048
references: Diabetes Care. 2005 Jul;28(7):1690-7
references: 15983321
references: Hypertens Res. 2009 Jul;32(7):625-30
references: 19461652
references: Int J Cardiol. 2009 Feb 6;132(1):114-20
references: 18190989
references: J Hum Hypertens. 1999 Jan;13 Suppl 1:S21-5; discussion S33-4
references: 10076917
references: Blood Press. 2010 Dec;19(6):359-65
references: 20491606
references: Hypertension. 2006 Oct;48(4):664-70
references: 16940231
references: Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1257-66
references: 12171785
references: Life Sci. 1991;49(25):PL223-8
references: 1745100
references: N Engl J Med. 2000 Mar 30;342(13):905-12
references: 10738048
references: Lancet. 2003 Apr 5;361(9364):1149-58
references: 12686036
references: Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):672-8
references: 20399087
references: Hypertens Res. 2013 Jul;36(7):608-13
references: 23425956
references: J Am Coll Cardiol. 2001 Jan;37(1):76-80
references: 11153776
references: Intern Med. 2006;45(1):1-4
references: 16467596
references: Am Heart J. 2005 Jan;149(1):e2
references: 15660025
references: Atherosclerosis. 2012 Jan;220(1):134-8
references: 22119063
references: Int J Cardiol. 2002 Nov;86(1):41-59
references: 12243849
references: Circulation. 1997 Nov 18;96(10):3314-20
references: 9396422
references: J Am Coll Cardiol. 2003 Oct 1;42(7):1161-70
references: 14522473
references: J Invasive Cardiol. 2001 Feb;13(2):93-7
references: 11176015
references: J Am Coll Cardiol. 2010 Mar 9;55(10 ):976-82
references: 20202514
references: J Am Coll Cardiol. 2009 Feb 3;53(5 Suppl):S35-42
references: 19179216
references: Hypertens Res. 2007 Dec;30(12 ):1219-30
references: 18344628
references: Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1876-82
references: 17172278
references: Hypertension. 2008 Mar;51(3):797-802
references: 18212273